Ming‐Che Lee
- Hepatology top 5%
- Liver Disease and Transplantation 7
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 6
- Nephrology top 5%
- Parathyroid Disorders and Treatments 8
- Surgery top 10%
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 5
-
- Bone health and treatments 9
- Polyomavirus and related diseases 6
-
- Metabolism, Diabetes, and Cancer 5
-
- Bone health and osteoporosis research 5
- Co-authors
- Bang‐Gee HsuWen‐Sheng WuTomohiro IshiiEishi TotsukaChung‐Jen LeeJohn J. FungTeng‐Yi LinRen-In You
- Cited by
- HepatologyTransplantationNephrology
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ming‐Che Lee
102 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 126
- Hepatology 235
- Transplantation 49
- Nephrology 96
- Surgery 479
- Infectious Diseases 170
Countries citing papers authored by Ming‐Che Lee
This map shows the geographic impact of Ming‐Che Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Che Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Che Lee more than expected).
Fields of papers citing papers by Ming‐Che Lee
This network shows the impact of papers produced by Ming‐Che Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Che Lee. The network helps show where Ming‐Che Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming‐Che Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 13 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 17 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 11 | |
| 12 | 2015 | 2 | |
| 13 | 2011 | 34 | |
| 14 | 2006 | 4 | |
| 15 | 2005 | 3 | |
| 16 | 2005 | 3 | |
| 17 | 2002 | 1 | |
| 18 | Ultrasound screening of neonatal adrenal hemorrhage. | 2001 | 11 |
| 19 | Adenocarcinoid: A rare primary appendiceal malignancy - Report of two cases and literature review | 1996 | 1 |
| 20 | 1996 | 14 |
About Ming‐Che Lee
Ming‐Che Lee is a scholar working on Transplantation, Nephrology, Hepatology, Orthopedics and Sports Medicine and Oncology, having authored 104 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bone health and treatments (9 papers), Parathyroid Disorders and Treatments (8 papers), Liver Disease and Transplantation (7 papers), Renal Transplantation Outcomes and Treatments (6 papers), Polyomavirus and related diseases (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Tuberculosis Research and Epidemiology (5 papers) and Bone health and osteoporosis research (5 papers). The work is most often cited by research in Hepatology (235 citations), Transplantation (49 citations), Nephrology (96 citations), Surgery (479 citations) and Infectious Diseases (170 citations). Ming‐Che Lee has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Bang‐Gee Hsu, Wen‐Sheng Wu, Tomohiro Ishii, Eishi Totsuka, Chung‐Jen Lee, John J. Fung, Teng‐Yi Lin, Ren-In You, Chuan-Chu Cheng and Yen‐Cheng Chen. Their work appears in journals such as Clinical Transplantation, PLoS ONE, Diabetes & Metabolism, Regulatory Peptides and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.